| Dr Nancy J Charest, MD | |
|
5 Washington Pl, Bedford, NH 03110-6736 | |
| (603) 695-2500 | |
| Not Available |
| Full Name | Dr Nancy J Charest |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Endocrinology |
| Location | 5 Washington Pl, Bedford, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487986840 | NPI | - | NPPES |
| 30209636 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 023678 (Connecticut) | Secondary |
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 14863 (New Hampshire) | Primary |
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Today's headlines highlight how Senate consideration of the health bill could become even messier with amendments pending on abortion funding restrictions and the reimportation of prescription drugs. All the while, Senate Dems continue to work to find common ground on the public option.
HyGreen™, developed by Xhale Innovations, Inc., has been selected as a winner in the 2010 Medical Design Excellence Awards competition, one of the most prestigious awards in the medical device industry. The announcement comes on the heels of winning the 2009 Popular Science Best of What's New Award, and is the latest success for this market-defining product.
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced the New Drug Application (NDA) for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), has been accepted for review by the U.S. Food and Drug Administration.
World-renowned scientists are taking what they've learned from their multicenter research collaboration studying the health impact of fatty acids on diverse populations to set up a genetics center in India.
› Verified 4 days ago
| Entity Name | Alliance Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891859419 PECOS PAC ID: 8022019215 Enrollment ID: O20070131000394 |
News Archive
Today's headlines highlight how Senate consideration of the health bill could become even messier with amendments pending on abortion funding restrictions and the reimportation of prescription drugs. All the while, Senate Dems continue to work to find common ground on the public option.
HyGreen™, developed by Xhale Innovations, Inc., has been selected as a winner in the 2010 Medical Design Excellence Awards competition, one of the most prestigious awards in the medical device industry. The announcement comes on the heels of winning the 2009 Popular Science Best of What's New Award, and is the latest success for this market-defining product.
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced the New Drug Application (NDA) for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), has been accepted for review by the U.S. Food and Drug Administration.
World-renowned scientists are taking what they've learned from their multicenter research collaboration studying the health impact of fatty acids on diverse populations to set up a genetics center in India.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy J Charest, MD 5 Washington Pl, Bedford, NH 03110-6736 Ph: (603) 695-2500 | Dr Nancy J Charest, MD 5 Washington Pl, Bedford, NH 03110-6736 Ph: (603) 695-2500 |
News Archive
Today's headlines highlight how Senate consideration of the health bill could become even messier with amendments pending on abortion funding restrictions and the reimportation of prescription drugs. All the while, Senate Dems continue to work to find common ground on the public option.
HyGreen™, developed by Xhale Innovations, Inc., has been selected as a winner in the 2010 Medical Design Excellence Awards competition, one of the most prestigious awards in the medical device industry. The announcement comes on the heels of winning the 2009 Popular Science Best of What's New Award, and is the latest success for this market-defining product.
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced the New Drug Application (NDA) for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), has been accepted for review by the U.S. Food and Drug Administration.
World-renowned scientists are taking what they've learned from their multicenter research collaboration studying the health impact of fatty acids on diverse populations to set up a genetics center in India.
› Verified 4 days ago
Alix Handelsman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 58 Hawthorne Dr, Bedford, NH 03110 Phone: 603-622-8619 | |
Dr. Stanley S Paras, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 58 Hawthorne Dr, Bedford, NH 03110 Phone: 603-622-8619 Fax: 603-625-0866 | |
Dr. Jennifer Pelli Packard, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 188 Route 101, Bedford, NH 03110 Phone: 603-663-8052 Fax: 603-663-8056 | |
Converse Peirce Hunter Jr., MD Pediatrics Medicare: Medicare Enrolled Practice Location: 25 S River Rd, Bedford, NH 03110 Phone: 603-695-2500 | |
Dr. Rochelle J Heit, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 58 Hawthorne Dr, Bedford, NH 03110 Phone: 603-622-8619 | |
Eric R Jackson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 25 Leavy Drive, Bedford, NH 03110 Phone: 603-472-5860 | |
Andrea Palumbo, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 360 Route 101, Unit 8, Bedford, NH 03110 Phone: 603-472-5860 Fax: 603-472-5918 |